Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

MRN posts 533% growth in first five years

August 1, 2012 Research and Development clinical trials, growth, results

From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …
News
Press release

Pfizer’s RA pill impresses in Phase III

August 1, 2012 Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …
News

Ariad files new blood cancer drug with the FDA

July 31, 2012 Research and Development, Sales and Marketing Ariad, CML, EMA, FDA, Glivec, blood cancer

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …
News
tulstrup

Soren Tulstrup to lead Shire’s genetics franchise

July 31, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …
Appointment

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012 Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …
News
david-meek

Novartis’ David Meek moves to Endocyte

July 30, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Endocyte, Novartis, appointment

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
Appointment
immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012 Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …
News

The fight over ‘Obamacare’ goes on

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare

The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …
Feature
anne_sutton

NHS Commissioning Board appoints key directors

July 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Sutton, Lyn Simpson, NHS Commissioning, PCT

The NHS Commissioning Board Authority has announced the appointment of the two director posts in the national leadership team of …
Appointment

Europe looking to revamp clinical trial laws

July 25, 2012 Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …
News

Parexel’s BioPharm Unit to aid smaller R&D firms

July 25, 2012 Research and Development Parexel, R&D, biotech

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …
News
bod_guiheen_lg

ADMA Biologics appoints Lawrence Guiheen to board of directors

July 25, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ADMA Biologics, Lawrence Guiheen

Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …
Appointment
Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012 Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …
News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012 Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …
News
Microneedles image

Microneedles could transform delivery of drugs to the eye

July 24, 2012 Manufacturing and Production, Research and Development AMD, avastin, microneedles

Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026